We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Preoperative Skin Preparation Prevents Surgical Site Infections

By HospiMedica International staff writers
Posted on 25 Jul 2012
A new review of studies suggests that preoperative antiseptic showers reduce bacterial colonization and may be effective at preventing surgical site infections (SSIs).

Researchers at the Canadian Agency for Drugs and Technologies in Health (CADTH; Ottawa, Canada), and the University of Manitoba (Winnipeg, Canada) conducted a systematic review of literature using Medline, EMBASE, and other databases, for the period between January 2001 to June 2011, in order to evaluate the clinical effectiveness of preoperative skin antiseptic preparations and application techniques for the prevention of SSIs. More...
Two researchers assessed each of the 20 studies included in the review and extracted data using standardized tables developed before the study.

The results of the reviews, which included data on 9,520 patients, indicated that presurgical antiseptic showering is effective for reducing skin flora, and may reduce SSI rates; the antiseptic application method, on the other hand, was found to be inconsequential. However, the researchers stressed that due to the heterogeneity of the studies and the results, conclusions about which antiseptic is more effective at reducing SSIs could not be drawn. The review was published on June 29, 2012, in Infection Control and Hospital Epidemiology.

“Disinfectant products are often mixed with alcohol or water, which makes it difficult to form overall conclusions regarding an active ingredient,” concluded lead author Chris Kamel, MSc, of the CADTH, and colleagues. “Large, well-conducted randomized controlled trials with consistent protocols comparing agents in the same bases are needed to provide unequivocal evidence on the effectiveness of one antiseptic preparation over another for the prevention of SSIs.”

SSIs occur in approximately 2%-5% of patients who undergo clean extra-abdominal surgeries, such as thoracic and orthopedic surgery, and in up to 20% of patients who undergo intra-abdominal surgery interventions. Topical agents applied to the skin preoperatively to reduce SSI risk include iodophor (such as povidone-iodine), alcohol, and chlorhexidine gluconate (CHG). CHG and PI can be mixed with either alcohol or water, which may have implications for effectiveness.

Related Links:

Canadian Agency for Drugs and Technologies in Health
University of Manitoba



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.